Position in GILD
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$96,144
+$58,654 QoQ
Shares Held
761
+182.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#1,998
of 2,266 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Jun 30, 2026CallValue
$353,752
CallShares
2,800
PutValue
$277,948
PutShares
2,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026One River Asset Management, LLC holds $204,055 across 2 Drug Manufacturers - General names. GILD ranks #2 (47.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
298 | $107,911 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
761 | $96,144 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $277,948 | 2,200 | Put | Sole | 2026-07-28 | |
| 2026-06-30 | $96,144 | 761 | Shares | Sole | 2026-07-28 | |
| 2026-06-30 | $353,752 | 2,800 | Call | Sole | 2026-07-28 | |
| 2026-03-31 | $37,490 | 269 | Shares | Sole | 2026-04-27 | |
| 2026-03-31 | $278,740 | 2,000 | Put | Sole | 2026-04-27 | |
| 2026-03-31 | $278,740 | 2,000 | Call | Sole | 2026-04-27 | |
| 2025-06-30 | $1,579,343 | 14,245 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||